aTyr Pharma, Inc.
COMPOSITIONS AND METHODS FOR TREATING NRP2-ASSOCIATED DISEASES
Last updated:
Abstract:
Provided are therapies, including standalone and combination therapies, for treating neuropilin-2 (NRP2)-associated diseases and conditions, which include the use of at least one histidyl-tRNA synthetase (HRS) polypeptide.
Status:
Application
Type:
Utility
Filling date:
26 Jul 2019
Issue date:
19 Mar 2020